Infertility Testing & Diagnosis

Infertility Testing & Diagnosis is a specialized reproductive diagnostic evaluation that executes systematic laboratory, endocrine, and anatomical testing across both reproductive partners to identify specific subfertility barriers and formulate targeted clinical treatment strategies.

Diagnostic Testing & Evaluation Guides

Core Clinical Guide

Am I Infertile Female? 5 Signs You Need to Get Tested Now

Evidence-based clinical analysis and patient guidance regarding am i infertile female? 5 signs you need to get tested now.

Patient Protocol

How Can Doctors Tell If You’re Infertile? Diagnostic Tests

Evidence-based clinical analysis and patient guidance regarding how can doctors tell if you’re infertile? diagnostic tests.

Diagnostic Standard

How Many IUIs Before IVF? When to Switch Treatments

Evidence-based clinical analysis and patient guidance regarding how many iuis before ivf? when to switch treatments.

Comprehensive Diagnostic Testing Protocol

A structured infertility evaluation is designed to systematically assess the five core biological pillars of reproduction: ovulatory function, ovarian reserve, pelvic and tubal anatomy, uterine cavity contour, and male seminal parameters. Initial female laboratory screening includes Day 3 serum follicle-stimulating hormone (FSH) and estradiol ($E_2$), anti-Müllerian hormone (AMH), thyroid-stimulating hormone (TSH), prolactin, and transvaginal ultrasound antral follicle counts (AFC).

Anatomical patency and uterine cavity morphology are interrogated using specialized radiographic or sonographic imaging. A Hysterosalpingogram (HSG) utilizes fluoroscopy and radiopaque contrast to confirm bilateral fallopian tubal patency, while Saline Infusion Sonohysterography (SIS) detects intracavitary polyps, submucosal fibroids, or intrauterine synechiae with high diagnostic accuracy. Concurrently, the male partner completes a standardized semen analysis to assess seminal health.

Core Infertility Diagnostic Test Matrix

Diagnostic ProcedureTiming in CycleBiological Target Evaluated
Anti-Müllerian Hormone (AMH)Any Cycle Day (Random)Granulosa cell follicular reserve
Day 3 FSH and EstradiolCycle Day 2, 3, or 4Pituitary-ovarian feedback loop
Transvaginal Antral Follicle CountEarly Follicular PhaseVisible resting follicle cohort
Hysterosalpingography (HSG)Cycle Days 6 to 11Fallopian tubal patency & uterine outline
Saline Sonohysterography (SIS)Cycle Days 6 to 11Endometrial cavity contour & pathology
Comprehensive Semen AnalysisAfter 2-5 days abstinenceSperm volume, count, motility, morphology

Curated Clinical Directory & Treatment Resources

Frequently Asked Clinical Questions

What does an AMH blood test tell you about your fertility?

Anti-Müllerian Hormone (AMH) reflects the size of a woman’s remaining egg supply (ovarian reserve) and predicts responsiveness to IVF stimulation. However, it does not measure egg quality or the ability to conceive naturally in any given month.

Is a hysterosalpingogram (HSG) test painful?

An HSG can cause moderate, cramp-like discomfort for 1 to 5 minutes as contrast fluid fills the uterine cavity and traverses the fallopian tubes. Pre-medicating with ibuprofen 30 to 60 minutes prior helps minimize cramping.

How long does a complete fertility workup take to finish?

A full diagnostic workup can typically be completed within a single menstrual cycle (approximately 3 to 4 weeks), allowing the reproductive endocrinologist to assemble a complete diagnostic picture and recommend tailored treatment.

Clinical Reference Notice: This clinical directory and educational reference compiles published reproductive endocrinology protocols, ASRM/SART benchmarks, and clinical research data for patient educational planning. It does not replace individualized diagnostic consultation with a licensed reproductive specialist.
Scroll to Top